Conversor de divisas | Calculadora de cambio de divisas

Mercados españoles abiertos en 7 hrs 17 min

S&P 500
5.070,55
+59,95(+1,20%)
Nasdaq
15.696,64
+245,33(+1,59%)
NIKKEI 225
37.552,16
+113,55(+0,30%)
Dólar/Euro
1,0703
-0,0001(-0,01%)
Petróleo Brent
88,57
+0,15(+0,17%)
Bitcoin EUR
62.074,37
-499,18(-0,80%)

Business Insider
Gen Z may have 50-year retirements, so start investing now, says UBS
Retirements are getting longer, and being comfortable after you stop working means beating inflation by 2 percentage points, say UBS strategists.
PR Newswire
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or in combination with androgen deprivation therapy (ADT) for the treatment of adult men with high-risk biochemical recurrent (BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are unsuitable for salvage-radiotherapy.
Investor's Business Daily
Dow Jones Futures: Market Rallies, But Big Tests Loom; Tesla Soars On 'Affordable' EV, Elon Musk
The rally attempt gained steam Tuesday. Tesla leapt late as it said an "affordable" EV is coming. Elon Musk is on the call.

Mi cartera de valores y mercados

Personalizar

Tu lista está vacía.

Mis listas de control

Inicia sesión para ver tu lista y añadir símbolos.